XOMA Corp
NASDAQ:XOMA
| Market Cap (Intraday) | 362.58M |
| Current PE | 27.27 |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $34.80 |
| 50-Day MA | $37.24 |
| 200-Day MA | $30.84 |
XOMA Corp Stock, NASDAQ:XOMA
2200 Powell Street, Suite 310, Emeryville, California 94608
United States of America
Phone: +1.510.204.7200
Number of Employees: 10
Description
XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.